Monday, June 11, 2018

NAADAC
NAADACNAADACNAADACNAADACNAADACNAADACNAADACNAADAC
NAADAC
June 8, 2018
Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection due to the Potential Presence of Particulate Matter
The Food and Drug Administration (FDA) is urging Naloxone carriers to check their product against a national recall list.  The maker of the drug, Hospira, has issued a voluntary recall of the opioid overdose reversal drug Naloxone due to the potential presence of embedded and loose particulate matter in the syringe plunger.
Please inform healthcare professionals in your network immediately.  The FDA includes information on the specific product lot numbers affected by this recall.
NAADAC
FacebookFacebookFacebook
NAADACThe Association for Addiction Professionals
44 Canal Center Plaza, Suite 301Alexandria, VA 22314
Phone: 703.741.7686 / 800.548.0497

Send to Friend |  | Subscribe | 
WEB-VERSION

Informz

No comments:

Post a Comment